Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?

Antigen-presentingcells B cell Cluster of differentiation Dendritic cells Human papillomavirus Macrophage

Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 15 03 2022
revised: 16 05 2022
accepted: 23 05 2022
pubmed: 1 6 2022
medline: 22 6 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

Viruses may transform infected cells into benign or malignant tumors, promoting cell growth and survival via various intracellular pathways. Some oncogenic DNA viruses, such as human papillomaviruses, can lead to squamous intraepithelial lesions and cervical cancer. Furthermore, the early HPV virus'soncoproteins have been attributed to cancer initiation and development and tumor-enhancing action. In addition to viral oncoproteins, antigen-presenting cells (APC) and the number of clusters of differentiation (CD) markers expressed on their surface play an essential role in disease progression or tumorigenesis inhibition. This article discussed the function of CD markers in the interaction between APCs and cancer cells, immune cells' function in the infection process, and finally infected cells' malignancy. We investigated targeting these markers as a novel insight to create a new therapeutic or diagnosis strategy to prevent cervical cancer progression.

Identifiants

pubmed: 35640377
pii: S1567-5769(22)00380-0
doi: 10.1016/j.intimp.2022.108896
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108896

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Auteurs

Parisa Shiri Aghbash (P)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Milad Shirvaliloo (M)

Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Ammar Khalo Abass Kasho (A)

Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; Iraqi Ministry of Higher Education and Scientific Research, Tal Afar University, Tal Afar, Iraq.

Farbod Alinezhad (F)

Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA.

Hans Nauwynck (H)

Laboratory of Virology, Ghent University, 9820 Merelbeke, Belgium. Electronic address: Hans.Nauwynck@UGent.be.

Hossein Bannazadeh Baghi (H)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: hbannazadeh@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH